"Realistically speaking, it is not easy for the domestic pharmaceutical and bio industry to stand out in the global market. It's time we set a specific and clear direction and strategy."

An industry expert with over 20 years of experience in pharmaceuticals in the U.S. who is currently serving as an advisor to government agencies in Korea responded so when asked about the status of Korea’s pharmaceutical and bio industry.

While a few domestic companies are making a mark in the global market, the expert explained that Korea still has a long way to go in the big picture.

The expert pointed to the difference in investments as a key example. When considering the trillions of